Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2021 ∙ JCVI
Use of the AstraZeneca COVID-19 (AZD1222) vaccine: updated JCVI statement, 7 May 2021
Recommendation Europe United Kingdom AstraZeneca COVID-19 vaccine COVID-19
Download:
2021 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 in pregnant and breastfeeding women
Recommendation Europe Belgium Pregnant women COVID-19
Download:
2021 ∙ Haute Autorité de Santé, Commission Technique des Vaccinations
Vaccination of people with a history of Covid-19
Recommendation Europe France dosing schedule COVID-19
Download:
2021 ∙ Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - AstraZeneca vaccine
Recommendation Europe France AstraZeneca COVID-19 vaccine COVID-19
Download:
2021 ∙ Haute Autorité de Santé
Vaccination strategy against Covid-19 - Janssen COVID-19 vaccine
Recommendation Europe France Janssen COVID-19 Vaccine COVID-19
Download:
2021 ∙ Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 - the Moderna Covid-19 mRNA (nucleoside modified) vaccine
Recommendation Europe France Moderna COVID-19 vaccine COVID-19
Download:
2021
Vaccination strategy against COVID19 in Spain
Recommendation Europe Spain booster dose Pfizer-BioNTech vaccine Moderna COVID-19 vaccine Janssen COVID-19 Vaccine COVID-19
Download:
2021 ∙ SAGE
WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply - 16 July 2021
Position paper Priority Groups COVID-19
Download:
2020 ∙ Singh, A.; Gupta, L.; Gupta, V.
Heterologous Protection to COVID-19 with BCG Vaccine: Deciphering the Reality Using Meta-Analysis Approach
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2020 ∙ Leeson, C. E. Ismail, A. Hashad, M. M. Elmansy, H. Shahrour, W. Prowse, O. Kotb, A.
Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
All age groups Tuberculosis COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
Loading...